Microbot Medical Inc. (MBOT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 350K 700K 1.1M Q2 '12: 248.8K Q3 '12: 264K Q4 '12: 211K Q1 '13: 284.2K Q2 '13: 281.7K Q3 '13: 324.8K Q4 '13: 45K Q1 '14: 23.6K Q2 '14: 242.2K Q3 '14: 82.4K Q4 '14: 883K Q1 '15: 21K Q2 '15: 30.1K Q3 '15: 37K Q4 '15: 29K Q1 '16: 23.2K Q2 '16: 29.3K Q3 '16: 32.8K Q1 '26: 105K Q2 '26: 241K Q3 '12 Q2 '13 Q1 '14 Q4 '14 Q3 '15 Q2 '16 Q2 '26

Gross Profit Quarterly

-750K -500K -250K 0 250K 500K 750K Q2 '10: 219.3K Q3 '10: 217.6K Q4 '10: 635.2K Q1 '11: 166.9K Q2 '11: 181.7K Q3 '11: 163.1K Q4 '11: 494.1K Q1 '12: 572.1K Q2 '12: 184.6K Q3 '12: 192.1K Q4 '12: 156K Q1 '13: 217.4K Q2 '13: 204.1K Q3 '13: 239K Q4 '13: 226.1K Q1 '14: 252.2K Q2 '14: 164.1K Q3 '14: 211.5K Q1 '26: 2K Q2 '26: -643K Q3 '10 Q2 '11 Q1 '12 Q4 '12 Q3 '13 Q2 '14 Q2 '26

Operating Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '21: -2.6M Q4 '21: -3.9M Q1 '22: -3.2M Q2 '22: -3.6M Q3 '22: -3.5M Q4 '22: -3.1M Q1 '23: -2.9M Q2 '23: -2.3M Q3 '23: -2.5M Q4 '23: -2.1M Q1 '24: -2.4M Q2 '24: -2.5M Q3 '24: -3.3M Q4 '24: -3.4M Q1 '25: -3M Q2 '25: -3.7M Q3 '25: -3.9M Q4 '25: -4.1M Q1 '26: -4.3M Q2 '26: -6.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-6M -4M -2M 0 2M 4M 6M Q3 '21: -2.6M Q4 '21: -3.9M Q1 '22: -3.2M Q2 '22: -3.5M Q3 '22: -3.5M Q4 '22: -3M Q1 '23: -2.9M Q2 '23: -2.3M Q3 '23: -2.4M Q4 '23: -3.2M Q1 '24: -2.4M Q2 '24: -2.5M Q3 '24: -3.2M Q4 '24: -3.4M Q1 '25: -2.6M Q2 '25: -3.5M Q3 '25: -3.6M Q4 '25: -3.5M Q1 '26: -3.7M Q2 '26: -5.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 350K 700K 1.1M Q1 '26: 103K Q2 '26: 884K Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q3 '21: -2.2M Q4 '21: -2.9M Q1 '22: -3M Q2 '22: -3.1M Q3 '22: -3M Q4 '22: -2.5M Q1 '23: -3.2M Q2 '23: -1.9M Q3 '23: -1.7M Q4 '23: -1.8M Q1 '24: -2.4M Q2 '24: -2M Q3 '24: -2.8M Q4 '24: -1.7M Q1 '25: -2.9M Q2 '25: -2.6M Q3 '25: -3.8M Q4 '25: -3.8M Q1 '26: -5.1M Q2 '26: -5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q4 '20: -1.9M Q1 '21: -2M Q2 '21: -2.3M Q3 '21: -2.2M Q4 '21: -2.9M Q1 '22: -3M Q2 '22: -3.2M Q3 '22: -3M Q4 '22: -2.5M Q3 '23: -1.7M Q1 '24: -2.4M Q2 '24: -2M Q3 '24: -2.8M Q4 '24: -1.7M Q1 '25: -2.9M Q2 '25: -2.6M Q3 '25: -3.9M Q4 '25: -3.8M Q1 '26: -5.2M Q2 '26: -5.1M Q1 '21 Q4 '21 Q3 '22 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q1 '21: 7.1M Q2 '21: 7.1M Q3 '21: 7.1M Q1 '22: 7.1M Q2 '22: 7.1M Q3 '22: 7.1M Q1 '23: 8M Q2 '23: 9.2M Q3 '23: 11.7M Q1 '24: 14.1M Q2 '24: 14.8M Q3 '24: 16.5M Q1 '25: 31.1M Q2 '25: 36.5M Q3 '25: 48.1M Q1 '26: 67.2M Q2 '26: 67.2M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.10 -1.40 -0.70 0.00 0.70 1.40 2.10 Q3 '21: -1.42 Q4 '21: -1.59 Q1 '22: -1.70 Q2 '22: -1.84 Q3 '22: -1.97 Q4 '22: -1.81 Q1 '23: -1.72 Q2 '23: -1.48 Q3 '23: -1.20 Q4 '23: -1.08 Q1 '24: -0.89 Q2 '24: -0.81 Q3 '24: -0.80 Q4 '24: -0.74 Q1 '25: -0.65 Q2 '25: -0.58 Q3 '25: -0.45 Q4 '25: -0.29 Q1 '26: -0.26 Q2 '26: -0.24 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.